Avicenna Clinical Research | Southwest Gastroenterology

Research site
9921 Southwest Highway, Oak Lawn, Illinois, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site


3 of 28
Status: Active
Trial type: Interventional
Funder type: Industry

A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease

The study consists of 4 sub-studies, as follows:Sub-study 1 (Randomized, double-blind, placebo controlled study) to evaluate the efficacy and safety...

Active, not recruiting
Crohn's Disease
Drug: Risankizumab SC
Drug: Risankizumab On-Body Injector (OBI)

Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. This study will evaluate how well risankiz...

Active, not recruiting
Crohn's Disease (CD)
Drug: Ustekinumab
Drug: Risankizumab

The goal of this clinical trial is to evaluate if the study drug, CIN-103, can help reduce the symptoms associated with irritable bowel syndrome with...

Irritable Bowel Syndrome With Diarrhea
Drug: CIN-103
Drug: Placebo

Clinical trials

Find clinical trialsTrials by location


© Copyright 2024 Veeva Systems